Metabolic management in overweight subjects with naive impaired fasting glycaemia by means of a highly standardized extract from cynara scolymus: A double-blind, placebo-controlled, randomized clinical trial

Phytotherapy Research

Volumn 28, Issue 1, 2014, Pages 33-41

  Rondanelli, Mariangela ^a   Opizzi, Annalisa ^a   Faliva, Milena ^a   Sala, Patrizio ^a   Perna, Simone ^a   Riva, Antonella ^b   Morazzoni, Paolo ^b   Bombardelli, Ezio ^b   Giacosa, Attilio ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b INDENA S P A   (Italy)

^c Policlinico di Monza   (Italy)

Author keywords

Cynara scolymus; dietary supplement; impaired fasting glycaemia; overweight

Indexed keywords

CHOLESTEROL; CYNARA SCOLYMUS EXTRACT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABSENCE OF SIDE EFFECTS; ADULT; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME;

CYNARA SCOLYMUS;

CYNARA SCOLYMUS; DIETARY SUPPLEMENT; IMPAIRED FASTING GLYCAEMIA; OVERWEIGHT;

ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; CHOLESTEROL; CYNARA SCOLYMUS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; OVERWEIGHT; PLANT EXTRACTS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84892435246     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4950     Document Type: Article

References (38)

1. American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases. 2002. The prevention or delay of type 2 diabetes. Diabetes Care 25: 742-749.
2. Arion WJ, Canfield WK, Ramos,. 1998. Chlorogenic acid analogue S 3483: a potent competitive inhibitor of the hepatic and renal glucose-6-phosphatase systems. Arch. Biochem. Biophys. 351: 279-285.
3. Arion WJ, Canfield WK, Ramos FC,. 1997. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch. Biochem. Biophys. 339: 315-322.
4. Arion WJ, Nordlie RC,. 1965. Liver glucose-6-phosphatase and pyrophosphate-glucose phosphotransferase: effects of fasting. Biochem. Biophys. Res. Commun. 20: 606-610.
5. Azzini E, Bugianesi R, Romano F,. 2007. Absorption and metabolism of bioactive molecules after oral consumption of cooked edible heads of Cynara scolymus L. (cultivar Violetto di Provenza) in human subjects: a pilot study. Br. J. Nutr. 97: 963-969.
6. DECODE Study Group, the European Diabetes Epidemiology Group. 2001. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch. Intern. Med. 161: 397-405.
7. Dickel ML, Rates SM, Ritter MR,. 2007. Plants popularly used for loosing weight purposes in Porto Alegre, South Brazil. J. Ethnopharmacol. 9: 60-71.
8. Eastman RC, Cowie CC, Harris MI,. 1997. Undiagnosed diabetes or impaired glucose tolerance and cardiovascular risk. Diabetes Care 20: 127-128.
9. Fantini N, Colombo G, Giori A,. 2010. Evidence of glycemia-lowering effect by a Cynara scolymus L. extract in normal and obese rats. Phytother. Res. 25: 463-466.
10. Frisancho AR,. 1984. New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly. Am. J. Clin. Nutr. 40: 808-819.
11. Garber AJ, Spann SJ,. 2008. An overview of incretin clinical trials. J. Fam. Pract. 57: S10-S18.
12. Glümer C, JÇ¿rgensen T, Borch-Johnsen K,. 2003. Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 26: 2335-2340.
13. Haber GB, Heaton KW, Murphy D, Burroughs LF,. 1977. Depletion and disruption of dietary fibre. Effects on satiety, plasma-glucose, and serum-insulin. Lancet 2: 679-682.
14. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H,. 1996. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 19: 1138-1141.
15. Hemmerle H, Burger HJ, Below P,. 1997. Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. J. Med. Chem. 40: 137-145.
16. Herling AW, Burger HJ, Schwab D,. 1998. Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system. Am. J. Physiol. 274: G1087-G1093.
17. Hernandez-Galicia E, Aguilar-Contreras A, Aguilar-Santamaria L,. 2002. Studies on hypoglycemic activity of Mexican medicinal plants. Proc. West. Pharmacol. Soc. 45: 118-124.
18. Hui H, Tang G, Go VL,. 2009. Hypoglycemic herbs and their action mechanisms. Chin Med 4: 11.
19. Hui H, Zhao X, Perfetti R,. 2005. Structure and function studies of glucagon-like peptide-1 (GLP-1): the designing of a novel pharmacological agent for the treatment of diabetes. Diabetes Metab. Res. Rev. 21: 313-331.
20. Karthikesan K, Pari L, Menon VP,. 2010. Combined treatment of tetrahydrocurcumin and chlorogenic acid exerts potential antihyperglycemic effect on streptozotocin-nicotinamide-induced diabetic rats. Gen. Physiol. Biophys. 29: 23-30.
21. Lupattelli G, Marchesi S, Lombardini R,. 2004. Artichoke juice improves endothelial function in hyperlipemia. Life Sci. 76: 775-782.
22. Matsui T, Ogunwande IA, Abesundara KJ, Matsumoto K,. 2006. Anti-hyperglycemic potential of natural products. Mini Rev. Med. Chem. 6: 349-356.
23. Modi P,. 2007. Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus. Curr. Drug Discov. Technol. 4: 39-47.
24. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ,; A1c-Derived Average Glucose Study Group. 2008 Translating the A1C assay into estimated average glucose values. Translating the A1C assay into estimated average glucose values. Diabetes Care 31: 1473-1478.
25. Neustadt J, Pieczenik SR,. 2008. Medication-induced mitochondrial damage and disease. Mol. Nutr. Food Res. 52: 780-788.
26. Rondanelli M, Giacosa A, Orsini F, Opizzi A, Villani S,. 2011. Appetite Control and Glycaemia Reduction in Overweight Subjects treated with a Combination of Two Highly Standardized Extracts from Phaseolus vulgaris and Cynara scolymus. Phytother. Res. doi: 10.1002/ptr.3425.
27. Saénz Rodriguez T, Garcìa Giménez D, de la Puerta Vàzguez R,. 2002. Choleretic activity and biliary elimination of lipids and bile acids induced by an artichoke leaf extract in rats. Phytomedicine 9: 687-693.
28. Saydah SH, Loria CM, Eberhardt MS, Brancati FL,. 2001. Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care 24: 447-453.
29. Schütz K, Muks E, Carle R, Schieber A,. 2006. Quantitative determination of phenolic compounds in artichoke-based dietary supplements and pharmaceuticals by high-performance liquid chromatography. J. Agric. Food Chem. 54: 8812-8817.
30. Segal HL, Washko ME,. 1959. Studies of liver glucose 6-phosphatase. III. Solubilization and properties of the enzyme from normal and diabetic rats. J. Biol. Chem. 234: 1937-1941.
31. Shan JJ, Rodgers K, Lai CT, Sutherland SK,. 2007. Challenges in natural health product research: The importance of standardization. Proc. West. Pharmacol. Soc. 50: 24-30.
32. Shaw JE, Sicree RA, Zimmet PZ,. 2010. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87: 4-14.
33. Simon C, Herling AW, Preibisch G, Burger HJ,. 2000. Upregulation of hepatic glucose 6-phosphatase gene expression in rats treated with an inhibitor of glucose-6-phosphate translocase. Arch. Biochem. Biophys. 373: 418-428.
34. Steer RA, Cavalieri TA, Leonard DM, Beck AT,. 1999. Use of the Beck Depression Inventory for Primary Care to screen for major depression disorders. Gen. Hosp. Psychiatry 21: 106-111.
35. Thompson Coon JS, Ernst E,. 2003. Herbs for serum cholesterol reduction: a systematic view. J. Fam. Pract. 52: 468-478.
36. Unwin N, Faughnan MS, Zimmet P, Alberti KG,. 2002. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet. Med. 19: 708-723.
37. Welsch CA, Lachance PA, Wasserman BP,. 1989. Dietary phenolic compounds: inhibition of Na + -dependent D-glucose uptake in rat intestinal brush border membrane vesicles. J. Nutr. 119: 1698-1704.
38. World Health Organization. Energy and Protein Requirements Report of a Joint FAO/WHO/UNU Expert Consultation. 1985. WHO Technical Report Series No. 724 WHO: Geneva, Switzerland.